简介：
Overview
This protocol outlines the induction of Acute Kidney Injury (AKI) in adult zebrafish using cisplatin as a nephrotoxic agent. It details the evaluation of the technique's reproducibility and methods for analyzing inflammation and cell death in renal tissue.
Key Study Components
Area of Science
- Nephrology
- Neurobiology
- Zebrafish Models
Background
- Cisplatin is a chemotherapy agent that can induce nephrotoxicity.
- Understanding AKI mechanisms is crucial for developing therapeutic strategies.
- Zebrafish are valuable models for studying kidney injury and regeneration.
- Flow cytometry and TUNEL assays are used to assess cellular responses.
Purpose of Study
- To establish a zebrafish model of AKI using cisplatin.
- To evaluate inflammation and cell death in renal tissues.
- To explore potential therapeutic targets for renal protection.
Methods Used
- Anesthetizing and weighing zebrafish for cisplatin injection.
- Monitoring fish for recovery and mortality post-injection.
- Isolating renal cells for flow cytometry analysis.
- Performing TUNEL assays to detect apoptotic cells.
Main Results
- Cisplatin induces a dose-dependent mortality rate in zebrafish.
- Flow cytometry provides quantitative insights into inflammatory states.
- TUNEL assays reveal the presence of apoptotic cells in kidney tissue.
- The model can be utilized for further research on renal regeneration.
Conclusions
- The zebrafish model effectively mimics AKI for research purposes.
- Cisplatin serves as a useful tool for studying nephrotoxicity.
- Findings may contribute to the development of renal protective therapies.
What is the role of cisplatin in this study?
Cisplatin is used as a nephrotoxic agent to induce Acute Kidney Injury in zebrafish.
How is kidney injury assessed in this model?
Kidney injury is assessed using flow cytometry and TUNEL assays to analyze inflammation and cell death.
What are the benefits of using zebrafish in kidney research?
Zebrafish provide a transparent model for observing kidney injury and regeneration processes in vivo.
What is the expected mortality rate after cisplatin injection?
Approximately 30% mortality is expected within the first 24 hours post-injection.
What techniques are used to analyze renal tissue?
Flow cytometry and TUNEL assays are employed to evaluate cellular responses in renal tissue.
Can this model be used for therapeutic testing?
Yes, this zebrafish model can be utilized to explore new therapeutic targets for renal protection.
繁體中文
